Approximately 80% of individuals who receive immune checkpoint inhibitors for advanced cancer do not respond to therapy, according to results of a cross-sectional analysis.The number of FDA-approved ...

Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.

Over the last 25 years, (ED) medications such as Viagra and others have become common and normal pieces of bedroom tool kit.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A previous study showed that aficamten is metabolized, in part, by the cytochrome P450 (CYP) enzyme 3A4 1. To further characterize its metabolic pathways, aficamten was evaluated with concomitant ...

VKH-like uveitis secondary to BRAF/MEK inhibitor therapy is significantly more common in patients being treated for melanoma compared with other malignancy types. Patients undergoing cancer therapy ...

A common but potentially dangerous vaginal infection that affects nearly 1 in 3 women globally should be considered a sexually transmitted disease, a new study says. Bacterial vaginosis ...

A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models Significantly accelerated the progress of drug discovery ...

and Cass. Problems have been particularly concentrated downtown, near the Boston Common, in Roxbury, the South End, Dorchester, and South Boston. There was an increase in 311 calls for needle ...

But just how common—or rare—is your eye color? Well, if you have brown eyes, congratulations—you’re in the majority, as HowStuffWorks explains. Nearly 80 percent of people worldwide have ...